Gilead CEO: 'Working at unprecedented speed' to snuff out COVID-19

In an open letter this weekend, Gilead Chairman and CEO Daniel O'Day outlined the company's work on remdesivir, its decision to switch to "expanded access" programs and more.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.